Holds one active US DMF for alogliptin, filing since 2016. Its 2024 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds one active US DMF for alogliptin, filing since 2016. Its 2024 FDA inspection closed as NAI, and its GMP is recognised in 1 market.
Holds 2 active US DMFs for alogliptin, filing since 2016. Its 2024 FDA inspection closed as NAI.
Holds one active US DMF for alogliptin, filing since 2018. Its GMP is recognised in 1 market.
Holds one active US DMF for alogliptin, filing since 2014.
Holds one active US DMF for alogliptin, filing since 2014.
Holds one active US DMF for alogliptin, filing since 2024.
Holds 2 active US DMFs for alogliptin, filing since 2024.
Registered with SFDA (Saudi Arabia) for alogliptin.
This page filters the worldwide Alogliptin manufacturer list to companies based in China. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Ask Fred which manufacturers are on record for alogliptin and what filings they hold.
Chat with Fred, your AI analyst